Loading news...
Astrana Health Inc. (NASDAQ: ASTH) stock on Tuesday fell around 22% to close at $21.48.
ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the open of the stock market on Monday, March 2, 2026.
Summary HARBOR CAPITAL ADVISORS, INC. reduced its stake in Astrana Health Inc (ASTH) by 1.66%, selling 4 shares and holding 237 shares valued at about
Astrana Health, Inc. (ASTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ALHAMBRA, Calif., Jan. 6, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the J.P.
Geode Capital Management LLC reduced its position in shares of Astrana Health, Inc. (NASDAQ: ASTH) by 1.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,053,336 shares of the company's stock after selling 13,805 shares during the period. Geode
Astrana Health, Inc. ( ASTH ) Q3 2025 Earnings Call November 6, 2025 5:30 PM EST Company Participants Brandon Sim - President & CEO Chan Basho - CFO, COO & Corporate Secretary Conference Call Participants Jailendra Singh - Truist Securities, Inc., Research Division Matthew Mardula - William Blair & Company L.L.C., Research Division Meghan Holtz - Jefferies LLC, Research Division Michael Ha Ryan Langston - TD Cowen, Research Division Thomas Walsh David Larsen - BTIG, LLC, Research Division Craig Jones - BofA Securities, Research Division Zachary Haggerty Eugene Mannheimer - Prime Executions, Inc., Research Division Presentation Operator Good day, everyone, and welcome to Astrana Health Third Quarter 2025 Earnings Call.
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.33 per share a year ago.
Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m.
ALHAMBRA, Calif. , Oct. 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2025, after the close of the stock market on Thursday, November 6, 2025.
ALHAMBRA, Calif. , Sept. 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that company management is participating at the Wells Fargo Healthcare Conference from Wednesday, September 3 rd to Thursday, September 4 th, the Morgan Stanley Global Healthcare Conference on Tuesday, September 9 th with a broadcasted Fireside Chat from 5:35PM – 6:10PM ET, as well as the Baird Healthcare Conference on Wednesday, September 10 th.
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Astrana Health, Inc. (ASTH) and U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Astrana Health, Inc. (ASTH) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
ASTH, BJRI, ADT, KT and GSL stand out with low EV-to-EBITDA ratios and strong earnings growth forecasts.
Astrana Health, Inc. (ASHT) Q2 2025 Earnings Conference Call August 7, 2025 5:30 PM ET Company Participants Brandon K. Sim - President & CEO Chandan Basho - CFO, COO & Corporate Secretary Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Craig Jones - BofA Securities, Research Division David Michael Larsen - BTIG, LLC, Research Division Hua Ha - Robert W.
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.4 per share a year ago.
Company to Host Conference Call on Thursday, August 7, 2025, at 2:30 p.m. PT/5:30 p.m.
Value investors can consider buying high earnings yield stocks like B, ASTH, STNE, PHIN and PAGP for handsome returns.
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Astrana Health, Inc. (ASTH) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
ALHAMBRA, Calif. , July 22, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2025, after the close of the stock market on Thursday, August 7, 2025.